These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 17848681
1. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Scheenen TW, Heijmink SW, Roell SA, Hulsbergen-Van de Kaa CA, Knipscheer BC, Witjes JA, Barentsz JO, Heerschap A. Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681 [Abstract] [Full Text] [Related]
2. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Shukla-Dave A, Hricak H, Moskowitz C, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357 [Abstract] [Full Text] [Related]
3. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM. AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350 [Abstract] [Full Text] [Related]
9. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Fütterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, Hulsbergen-Van de Kaa CA, Witjes JA, Krabbe PF, Heerschap A, Barentsz JO. Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484 [Abstract] [Full Text] [Related]
10. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J. Radiology; 2008 Jan; 246(1):177-84. PubMed ID: 18024434 [Abstract] [Full Text] [Related]
11. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. Radiology; 2004 Nov; 233(2):441-8. PubMed ID: 15375223 [Abstract] [Full Text] [Related]
16. Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy. Vilanova JC, Comet J, Barceló-Vidal C, Barceló J, López-Bonet E, Maroto A, Arzoz M, Moreno A, Areal J. Radiology; 2009 Oct; 253(1):135-43. PubMed ID: 19703854 [Abstract] [Full Text] [Related]
17. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178 [Abstract] [Full Text] [Related]
18. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935 [Abstract] [Full Text] [Related]